Your browser doesn't support javascript.
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19.
Della-Torre, Emanuel; Criscuolo, Elena; Lanzillotta, Marco; Locatelli, Massimo; Clementi, Nicola; Mancini, Nicasio; Dagna, Lorenzo.
  • Della-Torre E; Università Vita-Salute San Raffaele, Milan 20132, Italy.
  • Criscuolo E; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Lanzillotta M; Laboratory of Medical Microbiology and Virology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Locatelli M; Università Vita-Salute San Raffaele, Milan 20132, Italy.
  • Clementi N; Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Mancini N; Laboratory Medicine Service, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Dagna L; Università Vita-Salute San Raffaele, Milan 20132, Italy.
Lancet Rheumatol ; 3(12): e829-e831, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1488028
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Lancet Rheumatol Year: 2021 Document Type: Article Affiliation country: S2665-9913(21)00321-0

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Lancet Rheumatol Year: 2021 Document Type: Article Affiliation country: S2665-9913(21)00321-0